4
Changes in Ownership
Prime Medicine, Inc. Filed Acc 0001894562-25-000008
Options or other derivatives
- Chief Scientific Officer acquired 275,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Duffield Jeremy Chief Scientific Officer | 2025-02-27 | Grant or award · Stock Option (right to buy) | +275,000 | 275,000 | D | ||
Loading xslF345X05/wk-form4_1741050933.xml…